The pharmaceutical industry of Belarus is increasing the range and volume of meds production, as well as exports

Pharmaceutical enterprises in Belarus annually replenish their range with new meds, 95% of which are produced under the import substitution program and are generics of original brands. Work continues to create innovative products. One of them is a unique compound able to fight against cancer. The resulting chemical composition makes it possible to cure up to 80% of cancer types and, most importantly, to form an immunity. Clinical studies of the med show high survival rates in patients, even with stage 4. Every year, Belarusian medicines worth more than $200 million are exported to 37 countries. The key market is Russia.